March 24, 2014
COLUMBIA, Md. - W. R. Grace & Co. (NYSE: GRA) has introduced ProVance™ pre-packed columns, a portfolio of products for cost-effective purification of biologic drugs, specifically monoclonal antibodies (mAbs). Monoclonal antibodies are key therapeutic agents used to treat rheumatoid arthritis, cancer and other diseases. Currently in the U.S., mAbs constitute the single largest biologics product [...]
March 24, 2014
METTLER TOLEDO Process Analytics Division has released the 450TOC Portable Total Organic Carbon Analyzer for use in pure water and ultrapure water treatment applications. High purity water is used across a variety of industries for many applications, ranging from a main ingredient in pharmaceutical and cosmetic products, washing and rinsing processes for microelectronics manufacturing, to [...]
Brooks Automation and BioCision Announce Equity Investment and Strategic Collaboration
March 24, 2014
CHELMSFORD, Mass. and LARKSPUR, Calif. -- Brooks Automation, Inc. (Nasdaq:BRKS), a global provider of automated sample storage systems for compound management and biorepositories, and BioCision, LLC, a leader in advanced technology to improve biomaterial sample handling and standardization, today announced they have established a relationship to support the development of technologies to improve temperature control [...]
Integrated DNA Technologies Advances Human Health and Clinical Research
March 24, 2014
CORALVILLE, IA – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, is extending its portfolio of NGS panels with the addition of the xGen® Inherited Disease and Pan-Cancer Panels. Adding these to the xGen AML Panel which was launched at the end of last year, IDT now offers a range of panels for [...]
HEPREGEN LAUNCHES FIRST HUMAN HEPATOPACTM ASSAY KIT TO EVALUATE HEPATOTOXICITY IN THE LABORATORY
March 24, 2014
Phoenix, Arizona – Today, at the Society of Toxicology’s 53rd Annual Meeting, Hepregen Corporation, a leader in the development of next generation HepatoPacTM and HepatoMuneTM cell-based in vitro assay products announced the commercial launch of the company’s first HepatoPacTM kit designed specifically for toxicology applications. The kit contains one or more standard 96-well tissue culture [...]
ProteinSimple Appoints Joe Keegan and Chris van Ingen to its Board of Directors
March 24, 2014
Santa Clara, CA - ProteinSimple announced today the appointments of two independent members of the company's Board of Directors, Mr. Chris van Ingen and Dr. Joe Keegan. "Chris and Joe are two of the most respected leaders in the life science tool industry," commented Tim Harkness, CEO of ProteinSimple. "They bring tremendous depth of experience [...]
Dr. Claire Pomeroy Elected as BD Director
March 24, 2014
Franklin Lakes, N.J. -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced the election of Dr. Claire Pomeroy to its Board of Directors. Dr. Pomeroy, 58, is an expert in infectious diseases and a long-time advocate for public health and patients, especially those with HIV/AIDS. She is currently President of [...]
GE completes acquisition of strategic assets from Thermo Fisher Scientific
March 24, 2014
CHALFONT ST. GILES, UK -- GE (NYSE:GE) announced today that it has completed the acquisition of Thermo Fisher's HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses. The acquisition allows GE to expand its offering of tools, technologies and services for the discovery and manufacture of innovative new medicines, vaccines and [...]
March 24, 2014
Hamburg – The nano-experts from the Center for Applied Nanotechnology (CAN) GmbH expand their product portfolio by CANdots® Series G - His Detect, which is a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays. It is easy to handle, highly sensitive as well as time saving compared to standard methods available [...]
Thermo Fisher Scientific Completes Sale of Certain Biosciences Businesses to GE Healthcare
March 24, 2014
WALTHAM, Mass. - Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today announced that it has completed the sale of its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for $1.065 billion. The businesses will become part of GE [...]

